Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
06/2005
06/30/2005US20050143427 treating bone disorders of joint cartilage damage, osteoarthritis, rheumatoid arthritis, or joint inflammation, and pain associate with; antiinflammatory agent; 1-methyl-octahydroindole-2-carboxylic acid
06/30/2005US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
06/30/2005US20050143421 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
06/30/2005US20050143418 Pesticidal heterocycles
06/30/2005US20050143414 reacting 2-chlorophenylacetic acid or ester with claimed intermediate N,N'-bis-4,5,6,7-tetrahydro-[3,2-c]-thienopyridyl methane which is solid and can be crystallized; optical purity; no byproducts
06/30/2005US20050143398 mitogen-activated protein (MAP), p38 kinase ( alpha and beta)-associated conditions; antiinflammatory and antidiabetic agent; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, asthma
06/30/2005US20050142322 Optical recording media and dipyrrpomethene-metal chelate compounds
06/30/2005DE10354629A1 2-Ethyl-4,6-dimethyl-phenyl substituierte spirocyclische Tetramsäure-Derivate 2-ethyl-4,6-dimethyl-phenyl substituted spirocyclic tetramic acid derivatives
06/30/2005CA2545294A1 Tetronic and tetramic acids as inhibitors of beta-secrease
06/29/2005EP1548016A1 Multipurpose linker compounds and ligands and process for producing the same
06/29/2005EP1546134A1 Piperazine substituted aryl benzodiazepines
06/29/2005EP1274701B1 [1,4']-bipiperidine compounds
06/29/2005CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
06/29/2005CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/29/2005CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
06/28/2005US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity
06/28/2005US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse
06/23/2005WO2005056562A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds as ikk inhibitors
06/23/2005WO2005056561A1 Microcrystal and medicinal preparation containing the same
06/23/2005WO2004024081A3 Acetyl 2-hydroxy-1,3 diaminoalkanes
06/23/2005US20050137407 Reacting a 2,5-di(alkoxycarbonyl)-3,4-dihydroxythiophene or the alkali metal salt thereof with a ditosylate and cleaving the ester and decarboxylating the intermediate thus formed; used as monomers for pi-conjugated polymers
06/23/2005US20050137401 Process for the preparation of tetrahydrothieno [3,2-C] pyridine derivatives
06/23/2005US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic
06/23/2005US20050137216 Heterocyclic sodium/proton exchange inhibitors and method
06/23/2005US20050137215 Antiarthritic and antiinflammatory agents; analgesics; the proline derivatives do not displace gabapentin from alpha-2-delta receptors
06/23/2005US20050137188 Heterocyclic compounds
06/23/2005US20050136287 Coupling a boronic acid having a substituent and 2,5-dihalogen-3,4-dinitrothiophen in the presence of a base by adding a Pd-containing catalyst, reducing nitro groups into amino group; reacting intermediate with camphorquinone
06/23/2005CA2550136A1 Microcrystal and medicinal preparation containing the same
06/23/2005CA2548011A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds as ikk inhibitors
06/22/2005EP1544203A1 3,4-Dioxythiophene derivatives
06/22/2005EP1544202A1 Novel herbicides, usage thereof, novel thienopyrimidine derivatives, intermediates of the same, and process for production thereof
06/22/2005EP1543012A1 6h-thien 2, 3-b!pyrrole derivatives as antagonists of gonadotropin releasing hormone (gnrh)
06/22/2005EP1543011A2 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
06/22/2005EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases
06/22/2005CN1630653A Pyrazolyl-substituted heterocycles and their use as phytosanitary products
06/22/2005CN1630639A Novel pyridine- and quinoline-derivatives
06/21/2005US6909001 Cyclization of salicaldehyde with 3-(2-furyl)-3-oxopropane-nitrile, to form 2-amino-4-(2-furyl)-5H-chromeno(2,3-b) pyridine-3-carbonitrile, used as mitogen activated protein kinase inhibitors
06/16/2005WO2005054252A1 Crystal of hydrochloride of sulfoxide derivative
06/16/2005WO2005054234A2 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
06/16/2005WO2005054198A2 Therapeutics use of pyridinium compounds to modulate naadp activity
06/16/2005WO2005016255A3 Substituted tetrahydroquinolines, phenylacetic acids and benzoic acids as hepatocyte nuclear factor 4 (hnf-4 ) modulator compounds
06/16/2005WO2004058753A8 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase
06/16/2005WO2004046107A8 Indole derivatives as somatostatin agonists or antagonists
06/16/2005WO1990000853A8 Method of treating neurological disorders
06/16/2005US20050131056 2- thia-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
06/16/2005US20050131052 Useful in treatment of type 2 diabetes, insulin resistance, syndrome X, hyperinsulinaemia, hyperglucagonaemia, cardiac ischaemia and obesity
06/16/2005US20050131050 Reacting ethyl trifluoroacetate with 4'fluoroacetophenone and 4-sulphonamidophenyl hydrazine
06/16/2005US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
06/16/2005US20050131015 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
06/16/2005US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis
06/16/2005US20050130910 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; drug screening
06/16/2005US20050130221 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
06/16/2005DE10354628A1 2-Ethyl-4,6-dimethyl-phenyl-substituierte Tetramsäure-Derivate 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives
06/16/2005CA2547887A1 Protein modifier production inhibitor
06/16/2005CA2547791A1 Therapeutics use of pyridinium compounds to modulate naadp activity
06/15/2005EP1541198A1 Cycloalkyl compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
06/15/2005EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors
06/15/2005EP1539761A1 6,7-dihydro-5h-pyrazolo[1,2-a] pyrazol-1-ones which control inflammatory cytokines
06/15/2005EP1539733A2 Azabicyclic compounds are central nervous system active agents
06/15/2005EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
06/15/2005EP1539180A2 Compounds, compositions, and methods
06/15/2005EP1539159A1 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors
06/15/2005EP1373240B1 Retinoid x receptor modulators
06/15/2005EP1345609B1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists
06/15/2005EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
06/15/2005EP1259229B1 USE OF BENZO-THIENO[2,3-d]PYRIMIDINES HAVING PDE V INHIBITING ACTIVITY FOR THE TREATMENT OF ERECTILE DYSFUNCTION
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005EP1048658B1 Alicyclic acylated heterocyclic derivatives
06/15/2005EP0975602B1 Imidazole and imidazoline derivatives and uses thereof
06/15/2005CN1628113A Substituted indoles as alpha-1 agonists
06/15/2005CN1626534A Steroid receptor modulator compounds and methods
06/14/2005US6906205 Spiro and dispiro 1,2,4-trioxolane antimalarials
06/14/2005US6906093 Indolinone combinatorial libraries and related products and methods for the treatment of disease
06/14/2005US6906080 Antiinflammatory agents, analgesics, drug abuse, alcoholism
06/14/2005US6906063 For therapy and prophylaxis of thrombosis in a mammal
06/14/2005US6906062 Stable colour at ambient conditions of storage; treating psychological disorders
06/09/2005WO2005051957A1 Indolyl-thieno`3,4-b!pyrazin-3-one derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/09/2005WO2005051949A1 Novel condensed imidazole derivative
06/09/2005WO2005035537A3 Substituted tricyclic heterocycles and their uses
06/09/2005WO2004080410A3 Furanose-type bicyclic carbohydrates with biological activity
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005DE10351436A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen
06/09/2005CA2545478A1 Indolyl-thieno'3,4-bipyrazin-3-one derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/08/2005EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity
06/08/2005EP1536698A1 Novel nutraceutical compositions comprising biotin
06/08/2005EP1440075B1 Novel 3beta-amino azabicyclooctane heteroaromatic amide derivatives, preparation method and therapeutic uses thereof
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005CN1625402A Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2, 3-D)-pyrimidine for treating of urinary incontinence
06/08/2005CN1623984A Fused-ring compounds and use thereof as drugs
06/08/2005CN1623537A Biaryl sulfonamides and its using method
06/08/2005CN1205186C ACE inhibitor nitric salts
06/07/2005US6903223 Phenyldiazirine compounds and photoaffinity labeling reagent
06/07/2005US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903099 Heterocyclic amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular disorders and erectile dysfunction
06/07/2005US6903097 Heterocycle carboxamides as antiviral agents
06/07/2005US6903091 Kidney diseases; hypotensive agents; blood disorders
06/07/2005US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/02/2005WO2005049622A1 5-5-membered fused heterocyclic compound and use thereof as hcv polymerase inhibitor
06/02/2005WO2005049613A1 Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)